4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0000950170-25-002946
Chief Scientific Officer sold 4,000 shares at $12.51 ($50,040)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Michaelson Jennifer Chief Scientific Officer | 2025-01-06 | Sale 10b5-1 | −4,000 | $12.51 | $50,040 | 95,760 | D: show line 1 in the form |
| Open-market sales · 4,000 sh · avg $12.51 · $50,040 | |||||||
Loading xslF345X05/ownership.xml…